Derwent World Patents Index First View [331]

HOME : Support : Dialog Search Aids : Bluesheets	Add RSS \| What is RSS?
View Bluesheets by \| Database Name \| File Number \| Subject \| OneSearch Categories \| Search Options \|

	331
Derwent World Patents Index First View^SM

Last Loaded on Web: Thursday, May 01, 2008

Last Update To Bluesheet: April 24, 2006

Bluesheet Contents PDF version

File Description	Document Types Indexed	Contact	Additional Indexes	Map
Subject Coverage	Geographic Coverage	Terms and Conditions	Limit	Report Options
Tips	Special Features	Sample Record	Sort	Predefined Format Options
Dialog File Data	DIALINDEX/OneSearch Categories	Basic Index	Rank	Rates

File Description [top]

Derwent World Patents Index First View^SM is a companion database to Derwent World Patents Index^Ž, Files 351 and 352, and also to Derwent World Patents Index Extension, File 350. It has been designed to be searched in conjunction with DWPI^SM to give a complete view of all the published patent documents before their inclusion in DWPI.

DWPI First View content is created by:

Identification of all patent documents added to the DWPI production system that have not yet been released into DWPI
Extraction of bibliographic information for these work-in-progress patent documents immediately after the DWPI patent family equivalency search
Addition of author text data such as title, abstract, and main claim for some patent-issuing authorities
Addition of technical drawing images where available
Release of these work-in-progress records as DWPI First View updates

DWPI First View is a rolling file. New patent records remain in DWPI First View until all of the value-add has been created by Derwent editors. The completed record is then added to DWPI and the corresponding DWPI First View record is removed.

DWPI First View is a patents-based database, whereas DWPI is family based. Each patent record in DWPI First View is identified as a Basic or Equivalent patent. Most of the records in DWPI First View are new Basic patents, as the majority of Equivalent patents are added immediately to DWPI, without having been in DWPI First View. DWPI First View contains records for those Equivalent patents that cannot be added to DWPI until the corresponding Basic patent record has been added to DWPI. There may also be a small number of Equivalent patents in DWPI First View for which the Basic is already in DWPI because of the timing of the extraction process for each file. These equivalents are likely to be transferred to DWPI in the next update. Equivalent patent records in DWPI First View list the corresponding Basic patent number.

Tips [top]

USE FILE 331

to determine who is obtaining patents in a particular technology area; to monitor competitor activities; to discover new research ideas.

USE RANK

for statistical analysis of a data field such as patent assignee.
SELECT TOPIC; RANK CO
USE MAP

to save terms from a specific field for further searching.
SELECT TOPIC; MAP ICMA TEMP; B 351; EXS
USE REPORT

for a tabular display of key patent data such as assignee, class, number and date, in a set of records.
SELECT TOPIC; REPORT S1/PA,IC,PN,PD/ALL
USE OneSearch

to search File 331 and File 351 (or 350, or 352) simultaneously to find, for example, all documents published on a specific day by a specific authority.
B 331,351; S PC=US(S)PD=20040217

Subject Coverage [top]

All patentable technology.

Dialog File Data [top]

Dates Covered: current

File Size: rolling file of about 60,000 - 90,000 records

Update Frequency: Twice weekly approximately. (82 updates/year)

Document Types Indexed [top]

Patents

Geographic Coverage [top]

International

Special Features [top]

ERA Available
KWIC and HILIGHT Available
DIALOG Alert Available
IDPAT Available
Image Output Available
Chemical Name Segmentation Available
DIALORDER Supplier (ORDER DERWENT)
REPORT Available

DialIndex/OneSearch Categories [top]

ACRONYM CATEGORY NAME

CHEMPAT Chemical Patents

OILPAT Petroleum and Energy Patents

PATAMER American Patents

PATASIA Asia-Pacific Patents

PATENTCN Chinese Patents

PATENTEP European Patents

PATENTFR French Patents

PATENTJP Japanese Patents

PATENTS Patents

PATFAM Equivalent Patents/Families

PATWORLD Worldwide Patents

PHARMPAT Pharmaceutical Patents

TECHPAT Technology Patents

WPI DWPI

WPIJ DWPI for Japan

Contact [top]

DERWENT WORLD PATENTS INDEX FIRST VIEW is provided by Thomson Scientific. Questions about file content should be submitted by Web Form at www.thomsonscientific.com/support/techsupport/ or directed to:

Thomson Scientific
14 Great Queen Street
London, WC2B 5DF
England

Telephone: +44 20 7344 2800

Fax: +44 20 7344 2900

Thomson Scientific
Palaceside Bldg. 5F
1-1-1 Hitotsubashi, Chiyoda-ku
Tokyo 100-0003,
Japan

800 Line: +81 800 888 8855

Fax: +81 3 5218 6536

Thomson Scientific
3501 Market Street
Philadelphia, PA 19104

800 Line: +1 800 336 4474

Fax: +1 215 386 2911

Thomson Scientific
Six Battery Road #20-03
Singapore 049909
,

Telephone: +65 6879 4118

Fax: +65 6223 2634

Terms and Conditions [top]

For The Dialog Corporation's Redistribution and Archive Policy, enter HELP ERA online. The following terms and conditions also apply.

The online use by customers of the databases ( Derwent databases ) of Derwent Information ( Derwent ) and all data obtained from Derwent databases is subject to the following terms and conditions.

1. All data obtained from Derwent databases and all copyright therein is and shall at all times remain the property of Derwent.

2. All data obtained from Derwent databases are to be treated as strictly confidential and may not be copied, duplicated, translated into any language or in any way reproduced without the prior written consent of Derwent, except for internal use only non-subscribers may redistribute Derwent data obtained from the DIALOG service in accordance with The Dialog Corporation's ERA redistribution program. Redistribution for subscribers within sites covered by a Derwent subscription is already a benefit of that subscription.

3. The customer undertakes and agrees that:

(a) any searches against Derwent databases will be conducted by the customer's employees for the customer's internal use only, and the results of such searches will not be disclosed or transmitted to any third party, except as permitted in paragraphs 3(b) - 3(g) below;

(b) if the customer wishes to conduct searches on behalf of a third party, the customer will notify Derwent and obtain Derwent s written consent; searches on behalf of a third party will not be permitted unless and until permission has been granted by Derwent in writing;

(c) any search conducted on behalf of a third party must be performed directly by the customer's employees and will be solely for that third party;

(d) prior to any search being conducted on behalf of a third party the customer will ensure that the third party undertakes to the customer and Derwent that the results of such search are for that third party's own internal use only;

(e) whenever the customer obtains data from Derwent databases for a third party, the customer shall notify that third party in writing of the ownership by Derwent of the data concerned and all copyright therein;

(f) copies of online and offline prints must be conspicuously marked: FOR INTERNAL USE ONLY (c) THOMSON DERWENT 1997";

(g) the term "third party" does not refer to a patent issuing authority, such as a national Patent Office, where data obtained from Derwent databases is required by law or regulation in the normal conduct of the patent issuing authority's day-to-day business.

4. Output from online searches may be stored temporarily in electronic form for a maximum period of three months for the purpose of editing or reformatting the search results. For longer term storage, a Downloading Agreement with Derwent must be completed and the appropriate fees paid.

5. In the event of a breach by the customer, its employees or any third party, of any of these terms and conditions Derwent shall be entitled to terminate the customer's right of access to Derwent databases immediately without notice.

6. Derwent shall not in any circumstances be liable or responsible for the completeness or accuracy of any data comprised in the Derwent databases nor the transmission of such data and will not be liable for any indirect, consequential or economic loss of profit resulting directly or indirectly from the use by the customer or any third party of such data.

7. The customer will not assign any of its rights under these terms and conditions in whole or in part without the prior written consent of Derwent.

8. The invalidity, illegality or unenforceability in whole or in part of any of these terms and conditions shall not affect the validity, legality, and enforceability of the remaining terms and conditions.

9. These terms and conditions shall override and prevail over any other terms and conditions in any document or other communication used by the customer in effecting its subscription to the Derwent databases.*

10. These terms and conditions shall be governed by and construed in accordance with English law.

*For the purposes of this provision, this is in reference to direct agreement between Derwent Publications and the Customer organization.

Any questions concerning the interpretation of any of these conditions should be referred to the nearest Derwent office for clarification.

Dialog Standard Terms & Conditions apply.

SAMPLE RECORD [top]

FULL SAMPLE RECORD

DIALOG(R)File 331:Derwent WPI First View

(c) 2004 Thomson Derwent. All rts. reserv.

0000141553

/TI Engraftable human neural stem cells

CO=, PA= Patent Assignee: CHILDRENS MEDICAL CENT (CHIL-N) US; UNIV BRITISH COLUMBIA

CK=, CC= (UYBR-N) GB; UNIV PENNSYLVANIA (UYPE-N) US

AU=, IV= Inventor: SNYDER E Y; WOLFE J H; KIM S U

AU=, IV=, CY=, ST= Inventor Name & Address: Snyder Evan Y., , Jamaica Plain, MA, ; Wolfe John

CY=, ST=, CC= H., , Philadelphia, PA, ; Kim Seung U., , Vancouver, CA

LR= Correspondence: Nixon Peabody LLP,

Patent No Kind Date Applicat No Kind Date Update

PC=, PN=, PD=, PP=, UD=, TY= US 6680198 B1 20040120 US 99398299 A 19990920 200407 B

AC=, AN=, AD= US 98133873 A 19980814

PR= Priority: US 99398299 A 19990920

US 98133873 A 19980814

Filing Details:

Patent No Kind Lan Pg Filing Notes

FD=, PC=, PN=, PP=, LA=, AN= US 6680198 B1 ENG Cont of Application US 98133873

FT=, FD= Cont of Patent US 5958767 A

IC= International Patent Class - Main: C12N-005/08

CL= US Patent Class - Primary (Original): 435368000

Secondary (Original): 424093700

Field of Search: 435368000 435366000 435325000 424093700

Examiner Citations: Patent No Kind

CT=, PP= US 5624830 A

US 5750376 A

US 5753506 A

US 5851832 A

US 5968829 A

US 5980885 A

JN= Journals: Svendsen et al. Experimental Neurology 1996 137, 376-388.*

Snyder, E., et al., Nature (London) 374:367-370, 1995.

Weiss, S., et al., Trends Neurosci. 19:387-393, 1996.

McKay, R., Science 276:66-71, 1997.

Snyder, E., et al., Proc. Natl. Acad. Sci. USA 94:11663-11668, 1997.

Flax, J.D., et al., Nat. Biotech. 16: 1033-1039, 1998.

Topf, N., et al., Gene Ther. 5:507-513, 1998.

Original Abstract:

/AB, /TX FIRST SECTION ABSTRACT - Stable clones of neural stem cells (NSCs) have

been isolated from the human fetal telencephalon. In vitro, these

self-renewing clones (affirmed by retroviral insertion site) can

spontaneously give rise to all 3 fundamental neural cell types

(neurons, oligodendrocytes, astrocytes). Following transplantation into

germinal zones of the developing newborn mouse brain, they, like their

rodent counterparts, can participate in aspects of normal development,

including migration along well-established migratory pathways to

disseminated CNS regions, differentiation into multiple

developmentally- and regionally-appropriate cell types in response to

microenvironmental cues, and non-disruptive, non-tumorigenic

interspersion with host progenitors and their progeny. Readily

genetically engineered prior to transplantation, human NSCs are capable

of expressing foreign transgenes in vivo in these disseminated

locations. Further supporting their potential for gene therapeutic

applications, the secretory products from these NSCs can cross-correct

a prototypical genetic metabolic defect in abnormal neurons and glia in

vitro as effectively as do murine NSCs. Finally, human cells appear

capable of replacing specific deficient neuronal populations in a mouse

model of neurodegeneration and impaired development, much as murine

NSCs could. Human NSCs may be propagated by a variety of means--both

epigenetic (e.g., chronic mitogen exposure) and genetic (transduction

of the propagating gene vmyc)--that are comparably safe (vmyc is

constitutively downregulated by normal developmental mechanisms and

environmental cues) and effective in yielding engraftable, migratory

clones, suggesting that investigators may choose the propagation

technique that best serves the demands of a particular research or

clinical problem. All clones can be cryopreserved and transplanted into

multiple hosts in multiple settings.

/CM, /TX MAIN CLAIM - A primordial human neural stem cell clone comprising both

EGF and bFGF receptors maintained as a stable and identifiable cell

line in vitro and suitable for on-demand implantation in vivo into a

living host subject, said primordial human neural stem cell clone

comprising a pluripotent and self-renewing neural stem cell of human

origin, which

i) carries native human genomic DNA, which has not been genetically

modified by human intervention means;

ii) remains uncommitted and undifferentiated while passaged in vitro

using epigenetic means as a mitotic cell line;

iii) is capable of migrating in vivo after implantation from the

implantation site to another anatomic site for in vivo integration

within the nervous system of the living host subject;

iv) is capable of integrating in situ after implantation into the

parenchymal tissues at a local anatomic site in the living host

subject;

v) is capable of differentiating in situ into any one of neuronal cell

types selected from the group consisting of neurons, oligodendroglia

and astroglia as a response to signals in vivo; and

vi) expresses both EGF and bFGF receptors.

SAMPLE RECORD WITH EQUIVALENT PATENT

DIALOG(R)File 870:Derwent WPI First View

(c) 2004 Thomson Derwent. All rts. reserv.

0000122440

/TI Polymerization of addition polymerizable monomer(s) such as olefins,

involves contacting monomer(s) with metal complex and activating

cocatalyst, under additional polymerization condition and recovering

polymeric product

CO=, PA=, CK=, CC= Patent Assignee: DOW GLOBAL TECHNOLOGIES INC (DOWC-C) US

AU=, IV= Inventor: MULLINS M J; NICKIAS P N; BOONE H W; ATHEY P S; SOTO J; SNELGROVE

R V

Patent No Kind Date Applicat No Kind Date Update

PY=, AY=, TY= EP 1379561 A2 20040114 EP 2002763859 A 20020322 200405 E

AC=, AN=, AD= WO 2002US8758 A 20020322

PC=, PN=, UB=, TY= US 20020147287 A1 200405 B

PR= Priority: US 2001281349 P 20010404

Filing Details:

Patent No Kind Lan Pg Filing Notes

FD=, PP=, LA= EP 1379561 A2 ENG Based on Patent WO 200281530 A

CC=, DS= Designated States (Regional): AL AT BE CH CY DE DK ES FI FR GB GR IE IT LI

NC= LT LU LV MC MK NL PT RO SE SI TR (026 Countries)

IC= International Patent Class - Main: C08F-010/00

SAMPLE RECORD WITH MACHINE TRANSLATED ABSTRACT

DIALOG(R)File 331:Derwent WPI First View

(c) 2004 Thomson Derwent. All rts. reserv.

0000155991 **Image available**

/TI A micro pump, its manufacturing method, and an using method

CO=, PA=, CK=, CC= Patent Assignee: SUMITOMO ELECTRIC IND LTD (SUME-C) US

Patent No Kind Date Applicat No Kind Date Update

PC=, PN=, PD=, AC=,

AN=, AD=, UD=, TY= JP 2004011514 A 20040115 JP 2002165319 A 20020606 200407 B

PR= Priority: JP 2002165319 A 20020606

Filing Details:

Patent No Kind Lan Pg Filing Notes

FD=, PP=, LA= JP 2004011514 A JPN 11

IC= International Patent Class - Main: F04C-002/344

Unlinked: B81B-005/00, B81C-005/00, F04C-013/00, F04C-015/00,

F04C-018/344

Machine Translated Abstract:

FIRST SECTION ABSTRACT -

/AB, /TX A number of parts provides a micro pump with the few|small and

sufficient processing dimensional accuracy. Moreover, a lifetime is

long and provides the micro pump which can carry out the solution

sending also of the fluid of a high viscosity even in a thin flow path.

The micro pump of this invention is equipped with a housing part and a

rotor part, A rotor part has the spring which connects a rotor, the

movable vane, and a rotor and the movable vane. It is characterized by

a rotor, the movable vane, and a spring being integral construction. As

a spring to be used, a flat spring is preferable.

FIG. 1

ALERTING ABSTRACT - USES - This invention is related to the micro pump,

its manufacturing method, and the using method for conveying a trace

amount fluid.

ADVANTAGE - According to this invention, the micro pump with the

sufficient processing dimensional accuracy which has few number of

parts can be provided. This micro pump has a long lifetime and the

fluid of a high viscosity can also carry out a solution sending even in

a thin flow path.

The documents shown in these sample records may already have been transferred to Files 350, 351 and 352.

BASIC INDEX [top]

SEARCH
SUFFIX DISPLAY
CODE FIELD NAME
INDEXING
SELECT EXAMPLES

None None All Basic Index Fields^1,2 Word S NEURAL(W)STEM(W)CELLS

/AB AB Abstract³ Word S TRANSPLANT?(10N)MOUSE(W)BRAIN?/AB

/CM CM Main Claim⁴ Word S STEM(W)CELL(W)CLONE/CM

/NV NV Novelty⁵ Word S STEM(W)CELL?/NV

/TF TF Technology Focus⁵ Word S TRANSPLANTATION/TF

/TI TI Title⁶ Word S MICRO(W)PUMP/TI

/TX TX All Text (Abstract and Main Claim) Word S HUMAN(W)GENOMIC(W)DNA/TX

¹All words are indexed, including the standard Dialog stop words.

²All chemical names are indexed as complete words, e.g., CHLOROBENZENE, and chemically significant word segments, e.g., CHLORO and BENZENE. Words such as CHLOROBENZENE can be retrieved by either segment. Use /FW to restrict retrieval to a full word, e.g., S BENZENE/FW. Search locants which, indicate the position of chemical groups, as words, e.g., S 2(W)3(W)DI(W)CHLORO.

³Author Abstract in English for US documents; in English or a Romance language translation for EP, WO documents; an English translation for CN, JP, KR, TW, RU documents; and in German for DE documents. Derwent Abstract in English is present for any Equivalent patent for which the Basic is already in DWPI.

⁴Present for US documents in English. Present for EP documents in English or Romance language translation.

⁵Some headings are present only in Derwent prepared abstracts.

⁶Author Title is present for AU, GB, US documents in English; EP, WO documents in English or Romance language translation; CN, JP, KR, TW, RU documents in English translation; and DE documents in German. Derwent Title in English is present for any Equivalent for which the Basic is already in DWPI.

ADDITIONAL INDEXES [top]

SEARCH
PREFIX DISPLAY
CODE FIELD NAME
INDEXING
SELECT EXAMPLES

AC= AC Application Country Phrase S AC=US

AC= AC Application Country and Kind Phrase S AC=US B1

AC= PR Priority Application Country Phrase S AC=JP/PR

AC= PR Priority Application Country and Kind Phrase S AC=US A/PR

AD= AD Application Date Phrase S AD=19990920

AD= AD, PR Priority Application Date Phrase S AD=19980814/PR

AL= None Abstract Language⁷ Phrase S AL=ENG

AM= AD Application Month Phrase S AM=199909

AM= AD Priority Application Month Phrase S AM=199808/PR

AN= AN Application Number⁸ Phrase S AN=US 99398299
S AN=US 398299
S AN=US 398299-1999
S AN=1999US-398299
S AN=JP 2002165319
S AN=2002JP-165319

AN= AN Priority Application Number⁸ Phrase S AN=US 98133873/PR
S AN=US 133873/PR
S AN=US 133873-1998/PR
S AN=1998US-133873/PR
S AN=JP 2002165319/PR
S AN=2002JP-165319/PR

AU= AU, IV Author/Inventor⁹ Phrase S AU=SNYDER E Y
S AU=SNYDER EVAN Y.

AY= AY Application Year Phrase S AY=1999

AY= AY Priority Application Year Phrase S AY=1998/PR

None AZ DIALOG Accession Number

CC= CC All Patent Countries,Designated States, Inventor and Assignee Location¹⁰ Phrase S CC=US
S CC=CA/AU
S CC=US/PA

CK= CK Patent Assignee Code Phrase S CK=CHIL-N

CO= CO Company (Assignee) Phrase S CO=CHILDRENS MEDICAL CENT

DS= DS Designated States (All)¹¹ Phrase S DS=GB

DS= DS Designated States (National) Phrase S DS=GB/NA

DS= DS Designated States (Regional) Phrase S DS=GB/RN

DT= DT Document Type Phrase S DT=PATENT

FD= FD Patent Filing Details (Patent Number & Filing Detail Text) Phrase S FD=CONT OF
S FD=US 5958767

FT= FD Patent Filing Details Text Phrase S FT=CONT OF

GL= GL Geographic Location (Inventor/Legal Representative)^10,12 Word S GL=(JAMAICA(W)PLAIN)
S GL=MA/AU
S GL=(WASHINGTON AND DC)

None IM Image^13,14

None IS Image Statistic Data

IV= AU,IV Author/Inventor Phrase S IV=WOLFE J H
S IV=WOLFE JOHN H.

LA= LA Language Phrase S LA=ENG

LN= LN Latin Phrase S LN=IN VIVO

LR= LR Legal Representative¹² Word S LR=(NIXON(W)PEABODY)

LR= LR Legal Representative/Correspondence Address¹² Phrase S LR=NIXON PEABODY, LLP

NC= NC Number of Countries Phrase S NC=005

NP= NP Number of Patents Phrase S NP=001
S NP=002

PA= PA Patent Assignee Word
& Phrase S PA=(UNIV(W)BRITISH(W)COLUMBIA)
S PA=SUMITOMO ELECTRIC?

PA= PA Patent Assignee Code Phrase S PA=SUME-C
S PA=SUME/FF

PC= PB Patent Country (Basic) Phrase S PC=JP/PB

PC= PC Patent Country Phrase S PC=US

PC= PC Patent Country and Kind¹⁶ Phrase S PC=US B1

PC= PC Patent Country and Kind (Basic)¹⁶ Phrase S PC=US B1/PB
S PC=US B/PB
S PC=US/PB

PD= PD Patent Date Phrase S PD=20040120

PD= PD Patent Date (Basic) Phrase S PD=20040120/PB

None PI, SO Patent Family Table and Priority Data

PM= PD Patent Month Phrase S PM=200401

PM= PD Patent Month (Basic) Phrase S PM=200401/PB

PN= PN Patent Number⁸ Phrase S PN=US 6680198

PN= PN Patent Number (Basic)⁸ Phrase S PN=US 6680198/PB

PP= PP All Patent Numbers, Cited Patents and Patents from Filing Details⁸ Phrase S PP=US 5958767

PR= PR Priority Application Country, Number and Date¹⁵ Phrase S PR=US 99398299
S PR=JP 2002165319

PY= PY Publication Year Phrase S PY=2004

PY= PY Publication Year (Basic) Phrase S PY=2004/PB

RT= RT Record or Abstract Type¹⁷ Phrase S RT=IMAGE

SF= SF Special Feature Phrase S SF=REGISTERED TRADEMARK

SP= SP Species Phrase S SP=A. BAUMANII

SQ= SQ Gene or Peptide Sequence Phrase S SQ=GLU-THR-PRO
S SQ=GGYYAVAGYTCRTCRTG

TN= TN Registered Trademark Phrase S TN=EPOLEAD GT300

TY= None Type of Family Member¹⁸ Phrase S TY=B

UB= UB Update - Basic Patent Phrase S UB=200407

UD= UD Update - All Additions and Changes Phrase S UD=9999

UE= UE Update - Equivalent Patents Phrase S UE=200407

INDEXING AND CLASSIFICATION
CL= CL U.S. Class¹⁰ Phrase S CL=435368000
S CL=435

CL= CL U.S. Class - Primary Phrase S CL=435368000/OR
S CL=435368000/MA
S CL=435/OR
S CL=435/MA

FS= FS Field of Search Phrase S FS=435366000
S FS=435

HD= HD Abstract Heading⁵ Phrase S HD=USES

IC= IC International Patent Class¹⁰ Phrase S IC=F04C-002/344
S IC=F04C

IC= IC International Patent Class (Linkend) Phrase S IC='C07D-213/06'(S)IC='C07D-231/38'

IC= IC International Patent Class (Main) Phrase S IC=F04C-002/344/MA
S IC=F04C/MA

SH= SH Derwent Abstract Subheading Phrase S SH=POLYMERS

CITATIONS
CT= CT Cited Patents^10,19 Phrase S CT=US 5624830
S CT=US 5599980/AB
S CT=xx nnnnnn/AU
S CT=US 5624830/EX

JE= None Number of Examiner Journal Citations Numeric S JE=7

JN= JN Journal Citations Phrase S JN=SVENDSEN ET AL. EXP?

NA= None Number of Abstract Patent Citations Numeric S NA=3

NE= None Number of Examiner Patent Citations Numeric S NE=6

NR= None Total Number of Cited Journals Numeric S NR=7

NT= None Total Number of Cited Patents Numeric S NT=6

OA= None Number of Abstract Other Citations Numeric S OA=1

⁷If an abstract is present the abstract language may be ENG (English), FRE (French), or GER (German).

⁸Derwent source format is a fixed length field of 10 characters for Patent Numbers, e.g., EP--566354 or US-5263244, and 12 characters for Application Numbers, e.g., 93EP-0302843 or 92US-0870247 pre-Y2K. The fixed length is 12 characters for Patent Numbers, e.g., US2003000426, and 14 characters for Application Numbers, e.g., 2003WO-US00335 post-Y2K. For best results, use the Dialog format for cross-file searching or in OneSearch.

⁹Inventor names are present for documents from all countries except Japan.

¹⁰Special suffixes are used to further restrict the retrieval in appropriate prefixed fields as noted: /NA (National ); /RN (Regional); /PB (Patent Basic); /PR (Priority); /MA or /OR (Main or Original IPC or US Class); /MA (Main patent of the record); /AU (Author/Inventor); /EX (Examiner); PA (Assignee).

¹¹For EP and WO (PCT) documents only.

¹²Present for US documents only.

¹³Images are present only in AU, BE, BR, CA, CH, CN, CZ, DE, DK, EP, ES, FR, GB, HU, IE, JP, KR, MX, NL, PH, RO, RU, SK, TW, US, WO documents designated as Basic Patents.

¹⁴Images can be displayed when searches are conducted on the Internet using Dialog Web or DialogClassic. For modem connections, proper display of images requires DialogLink for Windows or DialogLink Version 1.2 or higher.

¹⁵The PR= field contains all priority data for the record; whereas the P1= field contains only the data for the first (earliest) priority in a record.

¹⁶Enter HELP KIND 351 or HELP KIND 352 online for definitions of the document kind codes.

¹⁷Record types include: Abstract, Citation, Derwent (abstract), Image, Machine translated (abstract), and Original (abstract).

¹⁸The following values are searchable in this index: B - Basic, E- Equivalent, N - Non-conventional family member, T- Equivalent treated as Basic, or UA - Patent family member unassigned.

¹⁹Cited patents are present in DE, EP, GB, JP, US, WO documents.

LIMIT [top]

Sets and terms may be limited by Basic Index suffixes, i.e., /DE, /AB (e.g., SELECT S3/AB).

SUFFIX FIELD NAME EXAMPLES

/ABS Abstract Present S S1/ABS

/ENG English Language Patent present S S2/ENG

/YYYY Publication Year S S1/2004

SORT [top]

SORTABLE FIELDS EXAMPLES

AD, AU, CK, IC, NP, PA, PD, PN, TI SORT S5/ALL/PD,D
PRINT S7/S/ALL/PA

RANK [top]

RANK FIELDS EXAMPLES

All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. RANK AU S3

MAP [top]

MAP FIELDS EXAMPLES

AN, ANPR, ANPRYY, AU, CK, CL, CLMA, CLOR, CLRV, CLUR, CO, CT, CTPN, FS, FSCL, FSIC, IC, ICMA, ICOR, PA, PN, PNCG, PNCT, PNPB
U.S. MAP: PNUS, ANUS, ANUSYY, ANPRUS, ANPRUSYY
Canada MAP: PNCA, ANCA, ANPRCA
Germany MAP: PNDE, ANDE, ANPRDE
EPO MAP: PNEP, ANEP, ANPREP
France MAP: PNFR, ANFR, ANPRFR
Great Britain MAP: PNGB, ANGB, ANPRGB
Japan MAP: PNJP, ANJP, ANPRJP
WIPO MAP: PNWO, ANWO, ANPRWO MAP ANPR TEMP S3

REPORT OPTIONS [top]

Output can be displayed in table format. REPORT codes with field lengths in parentheses are listed in the Search Options tables. Default table width is 72 characters; use SET H 132 to set maximum table width. REPORT S2/PN,PD,TI/ALL

USER-DEFINED FORMAT OPTIONS [top]

Display codes listed in the Search Options tables can be used to customize output. TYPE S3/PI,IM/ALL

PREDEFINED FORMAT OPTIONS [top]

NO.
DIALOGWEB
FORMAT RECORD CONTENT

1 -- DIALOG Accession Number

2 -- Basic Patent Record plus Abstract, Title, Patent Assignee, Inventor, International Patent Class, U.S. Class, Field of Search and Citation data

3 Medium Patent Family Table, Filing Details Table, plus Title, Patent Assignee, Inventor and Designated States

4 -- Full Record with Tagged Fields

5 -- Full Record, excluding Image

6 Free Dialog Accession Number

7 -- Full Record excluding Image

8 Short All International Patent Class, U.S. Class, and Field of Search codes

9 -- Full Record excluding Image

11 -- DIALOG Accession Number

12 -- Basic Patent Record (Format 2) plus Image

13 -- Brief Format (Format 23) plus Image

14 -- Full Record (Format 4) plus Image

15 -- Full Record (Format 5) plus Image

16 -- Summary Record (Format 36) plus Image

17 -- Full Record (Format 7) plus Image

19 Full Full Record (Format 9) plus Image

22 -- Basic Patent Record (Format 2) with Derwent source format Patent and Application Numbers

23 -- Brief Format with Title, Patent Assignee, and Abstract

25 -- Full Record with simplified Patent Family Table and Abstract

26 -- Title

27 -- Full Record with simplified Patent Family Table

28 -- Title, International Patent Class, U.S. Class, and Field of Search

29 -- Full Record (Format 9) with Derwent source format Patent and Application Numbers

34 Long Full Record (Format 7)

35 -- Abstract and Main Claim

36 -- Title, Abstract, and Main Claim

69 -- Image only

K -- KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats

DIRECT RECORD ACCESS [top]

FIELD NAME EXAMPLES

If the accession number of a specific record is known, it can be used to display the record directly. TYPE 00963610/IM
PRINT 8777225/6

Rates [top]

Rates For File: Derwent World Patents Index First View^SM[331] Standard Band1 Band2 Band3 Cost per DialUnit: $11.65 $9.35 $10.45 $13.00 Cost per Minute: $2.87 $2.30 $2.57 $3.20 Report Elements $0.45 $0.45 $0.50 $0.50 Rank Elements $0.05 $0.05 $0.06 $0.06 ALERT (default) $18.55 $14.85 $16.55 $20.70 ALERT (Monthly) * $94.35 $85.85 $95.75 $105.20 ALERT (Biweekly/twice a month) * $38.15 $30.55 $34.05 $42.55 ALERT (Weekly) $23.30 $18.55 $20.70 $26.00 ALERT (Calendar weekly) * $18.55 $14.85 $16.55 $20.70 * = custom scheduled Alerts only Band1 Band1 Band2 Band2 Band3 Band3 Format Types Prints Types Prints Types Prints Types Prints 1 $0.00 $0.07 $0.00 $0.06 $0.00 $0.07 $0.00 $0.08 2 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 3 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 4 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 5 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 6 $0.00 $0.07 $0.00 $0.06 $0.00 $0.07 $0.00 $0.08 7 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 8 $0.00 $0.07 $0.00 $0.06 $0.00 $0.07 $0.00 $0.08 9 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 11 $0.00 $0.07 $0.00 $0.06 $0.00 $0.07 $0.00 $0.08 12 $2.04 $2.55 $1.59 $2.04 $1.77 $2.28 $2.28 $2.85 13 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 14 $2.04 $2.55 $1.59 $2.04 $1.77 $2.28 $2.28 $2.85 15 $2.04 $2.55 $1.59 $2.04 $1.77 $2.28 $2.28 $2.85 16 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 17 $2.04 $2.55 $1.59 $2.04 $1.77 $2.28 $2.28 $2.85 19 $2.04 $2.55 $1.59 $2.04 $1.77 $2.28 $2.28 $2.85 22 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 23 $0.68 $0.85 $0.53 $0.68 $0.59 $0.76 $0.76 $0.95 25 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 26 $0.00 $0.07 $0.00 $0.06 $0.00 $0.07 $0.00 $0.08 27 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 28 $0.00 $0.07 $0.00 $0.06 $0.00 $0.07 $0.00 $0.08 29 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 34 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 35 $0.68 $0.85 $0.53 $0.68 $0.59 $0.76 $0.76 $0.95 36 $0.68 $0.85 $0.53 $0.68 $0.59 $0.76 $0.76 $0.95 37 $0.68 $0.85 $0.53 $0.68 $0.59 $0.76 $0.76 $0.95 46 $0.00 $0.07 $0.00 $0.06 $0.00 $0.07 $0.00 $0.08 49 $1.36 $1.70 $1.06 $1.36 $1.18 $1.52 $1.52 $1.90 59 $2.04 $2.55 $1.59 $2.04 $1.77 $2.28 $2.28 $2.85 69 $0.68 $0.85 $0.53 $0.68 $0.59 $0.76 $0.76 $0.95 KWIC95 $0.00 NA $0.00 NA $0.00 NA $0.00 NA KWIC96 $0.00 NA $0.00 NA $0.00 NA $0.00 NA REDIST/COPY Multiplier Table: Range Multiplier 1-2 1.00 3-25 1.50 26-100 3.00 101-200 4.00 201-500 6.00 501-1000 8.00 1001 or more 10.00 ARCHIVE Multiplier Table: Range Multiplier 1-25 1.50 26-200 3.00 201-500 6.00 501-1000 8.00 1001 or more 10.00 Standard = rate for all Non-Subscribers except those in Japan Band1 = rate for all Subscribers except those in Japan Band2 = rate for Subscribers in Japan Band3 = rate for Non-Subscribers in Japan
[top]

All contents Copyright © Thomson Reuters. All rights reserved.
If you have any questions about, problems with, or corrections for our Web site,
please contact Customer Service for assistance.

Dates Covered:	current
File Size:	rolling file of about 60,000 - 90,000 records
Update Frequency:	Twice weekly approximately. (82 updates/year)

ACRONYM	CATEGORY NAME
CHEMPAT	Chemical Patents
OILPAT	Petroleum and Energy Patents
PATAMER	American Patents
PATASIA	Asia-Pacific Patents
PATENTCN	Chinese Patents
PATENTEP	European Patents
PATENTFR	French Patents
PATENTJP	Japanese Patents
PATENTS	Patents
PATFAM	Equivalent Patents/Families
PATWORLD	Worldwide Patents
PHARMPAT	Pharmaceutical Patents
TECHPAT	Technology Patents
WPI	DWPI
WPIJ	DWPI for Japan


	`DIALOG(R)File 331:Derwent WPI First View`
	`(c) 2004 Thomson Derwent. All rts. reserv.`

	`0000141553`
/TI	`Engraftable human neural stem cells`
CO=, PA=	`Patent Assignee: CHILDRENS MEDICAL CENT (CHIL-N) US; UNIV BRITISH COLUMBIA`
CK=, CC=	`(UYBR-N) GB; UNIV PENNSYLVANIA (UYPE-N) US`
AU=, IV=	`Inventor: SNYDER E Y; WOLFE J H; KIM S U`
AU=, IV=, CY=, ST=	`Inventor Name & Address: Snyder Evan Y., , Jamaica Plain, MA, ; Wolfe John`
CY=, ST=, CC=	`H., , Philadelphia, PA, ; Kim Seung U., , Vancouver, CA`
LR=	`Correspondence: Nixon Peabody LLP,`


	`Patent No Kind Date Applicat No Kind Date Update`
PC=, PN=, PD=, PP=, UD=, TY=	`US 6680198 B1 20040120 US 99398299 A 19990920 200407 B`
AC=, AN=, AD=	`US 98133873 A 19980814`
PR=	`Priority: US 99398299 A 19990920`
	`US 98133873 A 19980814`

	`Filing Details:`
	`Patent No Kind Lan Pg Filing Notes`
FD=, PC=, PN=, PP=, LA=, AN=	`US 6680198 B1 ENG Cont of Application US 98133873`
FT=, FD=	`Cont of Patent US 5958767 A`

IC=	`International Patent Class - Main: C12N-005/08`
CL=	`US Patent Class - Primary (Original): 435368000`
	`Secondary (Original): 424093700`
	`Field of Search: 435368000 435366000 435325000 424093700`

	`Examiner Citations: Patent No Kind`
CT=, PP=	`US 5624830 A`
	`US 5750376 A`
	`US 5753506 A`
	`US 5851832 A`
	`US 5968829 A`
	`US 5980885 A`
JN=	`Journals: Svendsen et al. Experimental Neurology 1996 137, 376-388.*`
	`Snyder, E., et al., Nature (London) 374:367-370, 1995.`
	`Weiss, S., et al., Trends Neurosci. 19:387-393, 1996.`
	`McKay, R., Science 276:66-71, 1997.`
	`Snyder, E., et al., Proc. Natl. Acad. Sci. USA 94:11663-11668, 1997.`
	`Flax, J.D., et al., Nat. Biotech. 16: 1033-1039, 1998.`
	`Topf, N., et al., Gene Ther. 5:507-513, 1998.`


	`Original Abstract:`
/AB, /TX	`FIRST SECTION ABSTRACT - Stable clones of neural stem cells (NSCs) have`
	`been isolated from the human fetal telencephalon. In vitro, these`
	`self-renewing clones (affirmed by retroviral insertion site) can`
	`spontaneously give rise to all 3 fundamental neural cell types`
	`(neurons, oligodendrocytes, astrocytes). Following transplantation into`
	`germinal zones of the developing newborn mouse brain, they, like their`
	`rodent counterparts, can participate in aspects of normal development,`
	`including migration along well-established migratory pathways to`
	`disseminated CNS regions, differentiation into multiple`
	`developmentally- and regionally-appropriate cell types in response to`
	`microenvironmental cues, and non-disruptive, non-tumorigenic`
	`interspersion with host progenitors and their progeny. Readily`
	`genetically engineered prior to transplantation, human NSCs are capable`
	`of expressing foreign transgenes in vivo in these disseminated`
	`locations. Further supporting their potential for gene therapeutic`
	`applications, the secretory products from these NSCs can cross-correct`
	`a prototypical genetic metabolic defect in abnormal neurons and glia in`
	`vitro as effectively as do murine NSCs. Finally, human cells appear`
	`capable of replacing specific deficient neuronal populations in a mouse`
	`model of neurodegeneration and impaired development, much as murine`
	`NSCs could. Human NSCs may be propagated by a variety of means--both`
	`epigenetic (e.g., chronic mitogen exposure) and genetic (transduction`
	`of the propagating gene vmyc)--that are comparably safe (vmyc is`
	`constitutively downregulated by normal developmental mechanisms and`
	`environmental cues) and effective in yielding engraftable, migratory`
	`clones, suggesting that investigators may choose the propagation`
	`technique that best serves the demands of a particular research or`
	`clinical problem. All clones can be cryopreserved and transplanted into`
	`multiple hosts in multiple settings.`


/CM, /TX	`MAIN CLAIM - A primordial human neural stem cell clone comprising both`
	`EGF and bFGF receptors maintained as a stable and identifiable cell`
	`line in vitro and suitable for on-demand implantation in vivo into a`
	`living host subject, said primordial human neural stem cell clone`
	`comprising a pluripotent and self-renewing neural stem cell of human`
	`origin, which`

	`i) carries native human genomic DNA, which has not been genetically`
	`modified by human intervention means;`

	`ii) remains uncommitted and undifferentiated while passaged in vitro`
	`using epigenetic means as a mitotic cell line;`

	`iii) is capable of migrating in vivo after implantation from the`
	`implantation site to another anatomic site for in vivo integration`
	`within the nervous system of the living host subject;`

	`iv) is capable of integrating in situ after implantation into the`
	`parenchymal tissues at a local anatomic site in the living host`
	`subject;`

	`v) is capable of differentiating in situ into any one of neuronal cell`
	`types selected from the group consisting of neurons, oligodendroglia`
	`and astroglia as a response to signals in vivo; and`

	`vi) expresses both EGF and bFGF receptors.`

	`DIALOG(R)File 870:Derwent WPI First View`
	`(c) 2004 Thomson Derwent. All rts. reserv.`

	`0000122440`
/TI	`Polymerization of addition polymerizable monomer(s) such as olefins,`
	`involves contacting monomer(s) with metal complex and activating`
	`cocatalyst, under additional polymerization condition and recovering`
	`polymeric product`
CO=, PA=, CK=, CC=	`Patent Assignee: DOW GLOBAL TECHNOLOGIES INC (DOWC-C) US`
AU=, IV=	`Inventor: MULLINS M J; NICKIAS P N; BOONE H W; ATHEY P S; SOTO J; SNELGROVE`
	`R V`
	`Patent No Kind Date Applicat No Kind Date Update`
PY=, AY=, TY=	`EP 1379561 A2 20040114 EP 2002763859 A 20020322 200405 E`
AC=, AN=, AD=	`WO 2002US8758 A 20020322`
PC=, PN=, UB=, TY=	`US 20020147287 A1 200405 B`
PR=	`Priority: US 2001281349 P 20010404`

	`Filing Details:`
	`Patent No Kind Lan Pg Filing Notes`
FD=, PP=, LA=	`EP 1379561 A2 ENG Based on Patent WO 200281530 A`
CC=, DS=	`Designated States (Regional): AL AT BE CH CY DE DK ES FI FR GB GR IE IT LI`
NC=	`LT LU LV MC MK NL PT RO SE SI TR (026 Countries)`

IC=	`International Patent Class - Main: C08F-010/00`

	`DIALOG(R)File 331:Derwent WPI First View`
	`(c) 2004 Thomson Derwent. All rts. reserv.`

	`0000155991 Image available`
/TI	`A micro pump, its manufacturing method, and an using method`
CO=, PA=, CK=, CC=	`Patent Assignee: SUMITOMO ELECTRIC IND LTD (SUME-C) US`
	`Patent No Kind Date Applicat No Kind Date Update`
PC=, PN=, PD=, AC=,
AN=, AD=, UD=, TY=	`JP 2004011514 A 20040115 JP 2002165319 A 20020606 200407 B`
PR=	`Priority: JP 2002165319 A 20020606`

	`Filing Details:`
	`Patent No Kind Lan Pg Filing Notes`
FD=, PP=, LA=	`JP 2004011514 A JPN 11`

IC=	`International Patent Class - Main: F04C-002/344`
	`Unlinked: B81B-005/00, B81C-005/00, F04C-013/00, F04C-015/00,`
	`F04C-018/344`

	`Machine Translated Abstract:`
	`FIRST SECTION ABSTRACT -`
/AB, /TX	`A number of parts provides a micro pump with the few\|small and`
	`sufficient processing dimensional accuracy. Moreover, a lifetime is`
	`long and provides the micro pump which can carry out the solution`
	`sending also of the fluid of a high viscosity even in a thin flow path.`

	`The micro pump of this invention is equipped with a housing part and a`
	`rotor part, A rotor part has the spring which connects a rotor, the`
	`movable vane, and a rotor and the movable vane. It is characterized by`
	`a rotor, the movable vane, and a spring being integral construction. As`
	`a spring to be used, a flat spring is preferable.`

	`FIG. 1`

	`ALERTING ABSTRACT - USES - This invention is related to the micro pump,`
	`its manufacturing method, and the using method for conveying a trace`
	`amount fluid.`

	`ADVANTAGE - According to this invention, the micro pump with the`
	`sufficient processing dimensional accuracy which has few number of`
	`parts can be provided. This micro pump has a long lifetime and the`
	`fluid of a high viscosity can also carry out a solution sending even in`
	`a thin flow path.`

SEARCH SUFFIX	DISPLAY CODE	FIELD NAME	INDEXING	SELECT EXAMPLES
None	None	All Basic Index Fields^1,2	Word	S NEURAL(W)STEM(W)CELLS
/AB	AB	Abstract³	Word	S TRANSPLANT?(10N)MOUSE(W)BRAIN?/AB
/CM	CM	Main Claim⁴	Word	S STEM(W)CELL(W)CLONE/CM
/NV	NV	Novelty⁵	Word	S STEM(W)CELL?/NV
/TF	TF	Technology Focus⁵	Word	S TRANSPLANTATION/TF
/TI	TI	Title⁶	Word	S MICRO(W)PUMP/TI
/TX	TX	All Text (Abstract and Main Claim)	Word	S HUMAN(W)GENOMIC(W)DNA/TX

SEARCH PREFIX	DISPLAY CODE	FIELD NAME	INDEXING	SELECT EXAMPLES
AC=	AC	Application Country	Phrase	S AC=US
AC=	AC	Application Country and Kind	Phrase	S AC=US B1
AC=	PR	Priority Application Country	Phrase	S AC=JP/PR
AC=	PR	Priority Application Country and Kind	Phrase	S AC=US A/PR
AD=	AD	Application Date	Phrase	S AD=19990920
AD=	AD, PR	Priority Application Date	Phrase	S AD=19980814/PR
AL=	None	Abstract Language⁷	Phrase	S AL=ENG
AM=	AD	Application Month	Phrase	S AM=199909
AM=	AD	Priority Application Month	Phrase	S AM=199808/PR
AN=	AN	Application Number⁸	Phrase	S AN=US 99398299 S AN=US 398299 S AN=US 398299-1999 S AN=1999US-398299 S AN=JP 2002165319 S AN=2002JP-165319
AN=	AN	Priority Application Number⁸	Phrase	S AN=US 98133873/PR S AN=US 133873/PR S AN=US 133873-1998/PR S AN=1998US-133873/PR S AN=JP 2002165319/PR S AN=2002JP-165319/PR
AU=	AU, IV	Author/Inventor⁹	Phrase	S AU=SNYDER E Y S AU=SNYDER EVAN Y.
AY=	AY	Application Year	Phrase	S AY=1999
AY=	AY	Priority Application Year	Phrase	S AY=1998/PR
None	AZ	DIALOG Accession Number
CC=	CC	All Patent Countries,Designated States, Inventor and Assignee Location¹⁰	Phrase	S CC=US S CC=CA/AU S CC=US/PA
CK=	CK	Patent Assignee Code	Phrase	S CK=CHIL-N
CO=	CO	Company (Assignee)	Phrase	S CO=CHILDRENS MEDICAL CENT
DS=	DS	Designated States (All)¹¹	Phrase	S DS=GB
DS=	DS	Designated States (National)	Phrase	S DS=GB/NA
DS=	DS	Designated States (Regional)	Phrase	S DS=GB/RN
DT=	DT	Document Type	Phrase	S DT=PATENT
FD=	FD	Patent Filing Details (Patent Number & Filing Detail Text)	Phrase	S FD=CONT OF S FD=US 5958767
FT=	FD	Patent Filing Details Text	Phrase	S FT=CONT OF
GL=	GL	Geographic Location (Inventor/Legal Representative)^10,12	Word	S GL=(JAMAICA(W)PLAIN) S GL=MA/AU S GL=(WASHINGTON AND DC)
None	IM	Image^13,14
None	IS	Image Statistic Data
IV=	AU,IV	Author/Inventor	Phrase	S IV=WOLFE J H S IV=WOLFE JOHN H.
LA=	LA	Language	Phrase	S LA=ENG
LN=	LN	Latin	Phrase	S LN=IN VIVO
LR=	LR	Legal Representative¹²	Word	S LR=(NIXON(W)PEABODY)
LR=	LR	Legal Representative/Correspondence Address¹²	Phrase	S LR=NIXON PEABODY, LLP
NC=	NC	Number of Countries	Phrase	S NC=005
NP=	NP	Number of Patents	Phrase	S NP=001 S NP=002
PA=	PA	Patent Assignee	Word & Phrase	S PA=(UNIV(W)BRITISH(W)COLUMBIA) S PA=SUMITOMO ELECTRIC?
PA=	PA	Patent Assignee Code	Phrase	S PA=SUME-C S PA=SUME/FF
PC=	PB	Patent Country (Basic)	Phrase	S PC=JP/PB
PC=	PC	Patent Country	Phrase	S PC=US
PC=	PC	Patent Country and Kind¹⁶	Phrase	S PC=US B1
PC=	PC	Patent Country and Kind (Basic)¹⁶	Phrase	S PC=US B1/PB S PC=US B/PB S PC=US/PB
PD=	PD	Patent Date	Phrase	S PD=20040120
PD=	PD	Patent Date (Basic)	Phrase	S PD=20040120/PB
None	PI, SO	Patent Family Table and Priority Data
PM=	PD	Patent Month	Phrase	S PM=200401
PM=	PD	Patent Month (Basic)	Phrase	S PM=200401/PB
PN=	PN	Patent Number⁸	Phrase	S PN=US 6680198
PN=	PN	Patent Number (Basic)⁸	Phrase	S PN=US 6680198/PB
PP=	PP	All Patent Numbers, Cited Patents and Patents from Filing Details⁸	Phrase	S PP=US 5958767
PR=	PR	Priority Application Country, Number and Date¹⁵	Phrase	S PR=US 99398299 S PR=JP 2002165319
PY=	PY	Publication Year	Phrase	S PY=2004
PY=	PY	Publication Year (Basic)	Phrase	S PY=2004/PB
RT=	RT	Record or Abstract Type¹⁷	Phrase	S RT=IMAGE
SF=	SF	Special Feature	Phrase	S SF=REGISTERED TRADEMARK
SP=	SP	Species	Phrase	S SP=A. BAUMANII
SQ=	SQ	Gene or Peptide Sequence	Phrase	S SQ=GLU-THR-PRO S SQ=GGYYAVAGYTCRTCRTG
TN=	TN	Registered Trademark	Phrase	S TN=EPOLEAD GT300
TY=	None	Type of Family Member¹⁸	Phrase	S TY=B
UB=	UB	Update - Basic Patent	Phrase	S UB=200407
UD=	UD	Update - All Additions and Changes	Phrase	S UD=9999
UE=	UE	Update - Equivalent Patents	Phrase	S UE=200407
INDEXING AND CLASSIFICATION
CL=	CL	U.S. Class¹⁰	Phrase	S CL=435368000 S CL=435
CL=	CL	U.S. Class - Primary	Phrase	S CL=435368000/OR S CL=435368000/MA S CL=435/OR S CL=435/MA
FS=	FS	Field of Search	Phrase	S FS=435366000 S FS=435
HD=	HD	Abstract Heading⁵	Phrase	S HD=USES
IC=	IC	International Patent Class¹⁰	Phrase	S IC=F04C-002/344 S IC=F04C
IC=	IC	International Patent Class (Linkend)	Phrase	S IC='C07D-213/06'(S)IC='C07D-231/38'
IC=	IC	International Patent Class (Main)	Phrase	S IC=F04C-002/344/MA S IC=F04C/MA
SH=	SH	Derwent Abstract Subheading	Phrase	S SH=POLYMERS
CITATIONS
CT=	CT	Cited Patents^10,19	Phrase	S CT=US 5624830 S CT=US 5599980/AB S CT=xx nnnnnn/AU S CT=US 5624830/EX
JE=	None	Number of Examiner Journal Citations	Numeric	S JE=7
JN=	JN	Journal Citations	Phrase	S JN=SVENDSEN ET AL. EXP?
NA=	None	Number of Abstract Patent Citations	Numeric	S NA=3
NE=	None	Number of Examiner Patent Citations	Numeric	S NE=6
NR=	None	Total Number of Cited Journals	Numeric	S NR=7
NT=	None	Total Number of Cited Patents	Numeric	S NT=6
OA=	None	Number of Abstract Other Citations	Numeric	S OA=1

SUFFIX	FIELD NAME	EXAMPLES
Sets and terms may be limited by Basic Index suffixes, i.e., /DE, /AB (e.g., SELECT S3/AB).
/ABS	Abstract Present	S S1/ABS
/ENG	English Language Patent present	S S2/ENG
/YYYY	Publication Year	S S1/2004

NO.	DIALOGWEB FORMAT	RECORD CONTENT
1	--	DIALOG Accession Number
2	--	Basic Patent Record plus Abstract, Title, Patent Assignee, Inventor, International Patent Class, U.S. Class, Field of Search and Citation data
3	Medium	Patent Family Table, Filing Details Table, plus Title, Patent Assignee, Inventor and Designated States
4	--	Full Record with Tagged Fields
5	--	Full Record, excluding Image
6	Free	Dialog Accession Number
7	--	Full Record excluding Image
8	Short	All International Patent Class, U.S. Class, and Field of Search codes
9	--	Full Record excluding Image
11	--	DIALOG Accession Number
12	--	Basic Patent Record (Format 2) plus Image
13	--	Brief Format (Format 23) plus Image
14	--	Full Record (Format 4) plus Image
15	--	Full Record (Format 5) plus Image
16	--	Summary Record (Format 36) plus Image
17	--	Full Record (Format 7) plus Image
19	Full	Full Record (Format 9) plus Image
22	--	Basic Patent Record (Format 2) with Derwent source format Patent and Application Numbers
23	--	Brief Format with Title, Patent Assignee, and Abstract
25	--	Full Record with simplified Patent Family Table and Abstract
26	--	Title
27	--	Full Record with simplified Patent Family Table
28	--	Title, International Patent Class, U.S. Class, and Field of Search
29	--	Full Record (Format 9) with Derwent source format Patent and Application Numbers
34	Long	Full Record (Format 7)
35	--	Abstract and Main Claim
36	--	Title, Abstract, and Main Claim
69	--	Image only
K	--	KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats